23
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Proportion of Antibodies to the A and B Immunodominant Regions of Thyroid Peroxidase in Graves and Hashimoto Disease

&
Pages 211-216 | Received 23 Sep 2003, Accepted 12 Dec 2003, Published online: 07 Jul 2009
 

Abstract

Autoantibodies to thyroid peroxidase (TPO) predominately recognise conformational epitopes, restricted to two immunodominant regions (IDR) -A and -B. We have estimated the proportion of IDR-A and -B autoantibodies in 75 Hashimoto and 68 Graves patients sera. There were no statically significant differences between Hashimoto and Graves patients sera in the IDR-A and -B autoantibodies level, despite great differences between individual patients sera. In 75 Hashimoto patients sera, the mean value of IDR-A was 24.26%, IDR-B—52.26%, IDR (A+B)—76.66%, and to non-A, non-B regions—23.5%. In 68 Graves disease patients, the mean value of IDR-A was 24.87, IDR-B—54.29, IDR (A+B)—79.07, non-A, non-B—20.92%, at a single autoantibodies concentration 5 IU/ml. At high autoantibodies concentration (50 IU/ml) the proportion of autoantibodies to the IDR (A+B) diminished to 58% and to the non-A, non-B TPO regions increased to 42%. The autoimmune response to TPO regions outside the IDR (A+B) epitopes is stronger then previously assumed and this response is also conformation dependent.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.